LBP-010 - High efficacy and safety of grazoprevir and elbasvir for 8 weeks in treatment-naive, non-severe fibrosis HCV GT1b-infected patients: Interim Results of the STREAGER Study
| Autor: | Abergel, A., Hezode, C., Asselah, T., Larrey, D., Gournay, J., Loustaud-Ratti, V., Martino, V.D., Hubert, I.F., Samuel, D., Chanteranne, B., Dodel, M., Faure, F., Pereira, B., Lamblin, G., Campos, C., Muti, L., Reymond, M., Teilhet, C. |
|---|---|
| Zdroj: | In Journal of Hepatology April 2018 68 Supplement 1:S110-S110 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect